Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Phototherapy Equipment Market $500 Million by 2029

The global market for phototherapy equipment expected to attain $500 million by 2029, growing steadily at a CAGR of 4.0% over the forecast period, driven by increasing prevalence of skin diseases, the introduction of technologically advanced products, and rising prevalence of neonatal jaundice.

Global Phototherapy Equipment Market

Skin disease is one of the leading causes of global disease burden, affecting millions of people worldwide.1 Aging, environmental and genetic factors, and trauma can result in the development of a diverse set of skin diseases, with over 3000 entities identified in the literature.

  • Skin conditions pose a significant financial burden in the form of physician visits, hospital care, prescription drugs, and over-the-counter (OTC) products for treating or managing skin conditions, and indirect costs caused by productivity losses.
  • Nearly 85 million Americans (27% of population; 1 in 4 individuals) were seen by a physician for skin diseases. Skin disease is a significant and serious public health consideration for the US population, costing at least $75 billion to treat in a single year.

Phototherapy is the use of visible light to treat severe jaundice in the neonatal period. Approximately 60% of term babies and 85% preterm babies will develop clinically apparent jaundice, which classically becomes visible on day 3, peaks days 5-7 and resolves by 14 days of age in a term infant and by 21 days in the preterm infant.

  • Treatment with phototherapy is implemented in order to prevent the neurotoxic effects of high serum unconjugated bilirubin. Phototherapy is a safe, effective method for decreasing or preventing the rise of serum unconjugated bilirubin levels and reduces the need for exchange transfusion in neonates.
    • The mechanism of action for phototherapy devices varies with disease and treatment modality used, but it is thought that UV light may aid in the modulation of the immune response underlying various inflammatory and autoimmune dermatologic conditions.
      • Treatment modalities include broadband UVB (BBUVB, 280–315 nm), narrowband UVB (NBUVB, 311–313 nm), UVA (315–400 nm) alone or in combination with psoralen (psoralen 1 UVA; PUVA), combination UVA and UVB (UVAB, 280–400 nm), and the excimer laser (308 nm). Indications for the use of these modalities differ depending on the disease, age of the child, and desired outcome.

The global market for phototherapy equipment research report provides market size ($million 2019 to 2029), market share analysis, growth trends and forecast (CAGR%, 2023 to 2029).

The global market for phototherapy equipment segmented by product [conventional phototherapy equipment (conventional phototherapy equipment (fluorescent lamp), conventional phototherapy equipment (compact fluorescent lamp)], LED phototherapy equipment, fiber optic phototherapy equipment), by application [skin disease treatment (psoriasis, vitiligo, eczema, others), neonatal jaundice management], by end user (hospitals and clinics, homecare), and geography.

  • Based on the products, the LED phototherapy equipment segment accounted for the largest share of the total phototherapy equipment market, and also anticipated to grow at the fastest rate in the coming years.
    • The field of newborn phototherapy (PT) has clearly arrived at a strategic period of transition from the use of traditional light sources, such as fluorescent, halogen and halogen/fiberoptic, towards the use of presently fast developing, versatile solid state light emitting diode (LED) technology.
      • In resource limited settings, fluorescent devices are commonly used and are often locally produced. When new, these models may be efficacious. However, fluorescent bulbs need frequent replacement. In practice such devices often have burnt out bulbs or have bulbs that have been replaced with low irradiance white light. The most commonly used lamps in phototherapy machine are fluorescent lamps. Although these lamps are inexpensive and affordable, the light emission and the intensity drops over time.
      • LED-based systems have become increasingly popular in high-resource settings for their intensive irradiance and low maintenance requirements. Because of a rapidly expanding global market for PT devices, the medical device industry, particularly in developing countries, appears to be actively engaged in the production of newer and, undoubtedly, more effective and affordable LED-based devices. Today, in phototherapy devices, LED lamps are preferred over other types of lamps because of narrower bandwidth, less heat generation, high light intensity, small size, lighter weight, non-fragile and have low power consumption.
        • Low-cost LED units offer 10-year bulb lives while meeting the American Academy of Pediatrics (AAP) intensive phototherapy standard. More radical, ultra-low-cost treatments under development include blue filters for use under direct sunlight.
    • Fiber-optic phototherapy is a new technology that has been used to treat neonatal jaundice using optical fibers. This device has low power and spectral radiation because the body absorbs some of the radiation. However, the advantages include treatment and baby care without separation from the mother, and no retina damage and complications such as inflammation, corneal or the eye irritation, etc. due to direct transmission of light to the baby’s body.
  • In terms of applications, the skin disorders segment dominated the total phototherapy market, whereas the neonatal jaundice management segment estimated to expand at the fastest CAGR throughout the forecast period.
    • Phototherapy has been used successfully to treat a wide range of dermatologic conditions in adults. Given the growing body of evidence demonstrating its efficacy and safety in this population, the use of phototherapy as a treatment modality for pediatric skin conditions has become more widely accepted.
      • Some of the childhood dermatoses in which phototherapy has been used successfully include vitiligo, eczema / atopic dermatitis (AD), psoriasis, alopecia areata (AA), pityriasis lichenoides (PL), and mycosis fungoides (MF), among others.
    • Phototherapy may be considered after failure of topical treatment modalities or in extensive or rapidly progressive disease in pediatric patients. Historically, PUVA was commonly used in the treatment of vitiligo, but it has now largely been replaced by NBUVB because of excellent repigmentation outcomes and the potential risks associated with PUVA in children.
      • Phototherapy is recommended as a second-line treatment in patients with moderate to severe AD, and several studies have demonstrated its efficacy in pediatric patients. NBUVB is the preferred treatment modality owing to strong evidence documenting its efficacy, safety, and ease of administration in children with psoriasis. Furthermore, special considerations must be taken when using phototherapy in the pediatric population, such as safe delivery, scheduling, and long-term safety.
    • Phototherapy is one of the most commonly used devices for the treatment of neonatal jaundice, as bilirubin reacts to the green and the blue light. One of the most effective and safe methods for treating neonatal jaundice is using light therapy or phototherapy. This device uses fluorescent lamps, tungsten-halogen bulbs, LEDs, optical fibers, etc.
      • Phototherapy devices have different types, each with advantages over their predecessors. In existing models, because of their unique features like high sensitivity to bilirubin reduction, higher power, and efficiency, lighter, lower heat generation, lower cost and longer life devices, LED light sources are widely used in phototherapy devices.
  • Among the end users, the hospitals and clinics segment held the majority revenue share the total phototherapy equipment market, while the homecare segment expected to register the fastest growing rate during the next few years.
    • In order to assist physicians, hospitals, and clinic administrators with the selection of the most appropriate device for their clinical needs, it is important that uniform and comprehensive device characterizations and criteria be established and made available. Thus, it is becoming increasingly important that devices be evaluated for their physical and spectrophotometric characteristics as well as their clinical efficacy to affect the photochemical alteration of bilirubin (BR) in the newborn skin and circulation.
      • Most skin conditions treated with phototherapy require treatment sessions 2- 3 times per week, making scheduling treatments difficult. In children, a trial of in-clinic therapy to demonstrate efficacy and tolerability for each child is strongly recommended. However, in many cases, obtaining home units may be preferable for convenience, and also help in alleviating anxiety among children.
        • In addition, many home units have open designs, which are less intimidating than hospital or clinic units. These benefits may be outweighed by the fact that home units often require longer sessions and may be cost-prohibitive, because obtaining insurance coverage can be challenging.

The global market for phototherapy equipment research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • By geographical distribution, the North America region led the global phototherapy equipment market, followed by the Europe region. However, the Asia Pacific region projected to witness the fastest growth rate during the forecast period.
    • According to the American Academy of Dermatology (AAD) and the Society for Investigative Dermatology (SID), the skin conditions are among the most common health problems in the United States, collectively exceeding the prevalence of conditions such as obesity, hypertension, and cancer.
      • The substantial changes in the practice of dermatology and the US healthcare system include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population.
        • The costs and prevalence of skin disease are comparable with or exceed other diseases with significant public health concerns, such as cardiovascular disease and diabetes.

In addition, the global market for phototherapy equipment report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major companies operating in the global market for phototherapy equipment and profiled in this report include Atom Medical Corporation, Dräger, Fanem Medical, GE Healthcare, Hebert Waldmann GmbH & Co. KG, Medela, National Biological Corporation, Natus Medical, Inc., Nice Neotech Medical Systems Pvt. Ltd., Philips Lighting Holding B.V. (Signify Holdings), Phoenix Medical Systems Pvt. Ltd., Solarc Systems, Inc., and The Daavlin Company.

  • Product
    • Conventional Phototherapy Equipment
      • Conventional Phototherapy Equipment (Fluorescent Lamp)
      • Conventional Phototherapy Equipment (Compact Fluorescent Lamp)
    • LED Phototherapy Equipment
    • Fiber Optic Phototherapy Equipment
  • Application
    • Skin Disease Treatment
      • Psoriasis
      • Vitiligo
      • Eczema
      • Others
    • Neonatal Jaundice Management
  • End User
    • Hospitals & Clinics
    • Homecare
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Atom Medical Corporation
    • Dräger
    • Fanem Medical
    • GE Healthcare
    • Hebert Waldmann GmbH & Co. KG
    • Medela
    • National Biological Corporation
    • Natus Medical, Inc.
    • Nice Neotech Medical Systems Pvt. Ltd.
    • Philips Lighting Holding B.V (Signify Holdings)
    • Phoenix Medical Systems Pvt. Ltd.
    • Solarc Systems, Inc.
    • The Daavlin Company

To request Table of Contents and Sample Pages of this report:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com